Definium Therapeutics, Inc. (DFTX)
Since Mar 28, 2022, Definium Therapeutics, Inc. (DFTX) has reported earnings 18 times. On average the shares move ±5.49% post-earnings, with a positive reaction 55.6% of the time. Its largest post-earnings gain was +14.44% (Nov 02, 2023) and its largest decline was -7.64% (Aug 03, 2023). The next earnings report is predicted for 2026-07-13 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
18
Avg Abs. Movement
±5.49%
Positive %
55.6%
Negative %
44.4%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 07, 2026 | ☽ POST | $23.38 | $23.45 | $23.24 | 71,797 | -5.03% | open_in_new |
| Feb 26, 2026 | ☽ POST | $17.54 | $17.60 | $17.29 | 1,124,100 | +0.93% | open_in_new |
| Nov 06, 2025 | ☽ POST | $11.45 | $11.70 | $11.34 | 1,480,300 | +3.17% | open_in_new |
| Jul 31, 2025 | ☽ POST | $9.01 | $9.40 | $9.09 | 1,218,200 | -7.15% | open_in_new |
| May 08, 2025 | ☀ PRE | $6.51 | $6.71 | $6.46 | 1,199,500 | -1.97% | open_in_new |
| Mar 06, 2025 | ☀ PRE | $6.06 | $6.83 | $6.61 | 2,050,300 | +3.61% | open_in_new |
| Nov 07, 2024 | ☽ POST | $6.93 | $8.04 | $7.52 | 3,495,200 | +12.9% | open_in_new |
| Aug 13, 2024 | ☀ PRE | $7.20 | $7.25 | $6.59 | 1,374,700 | -3.8% | open_in_new |
| May 08, 2024 | ☽ POST | $9.35 | $9.92 | $9.61 | 969,400 | -5.1% | open_in_new |
| Feb 28, 2024 | ☀ PRE | $5.22 | $5.54 | $5.35 | 2,069,100 | -3.78% | open_in_new |
| Nov 02, 2023 | ☽ POST | $2.57 | $2.71 | $2.70 | 440,500 | +14.44% | open_in_new |
| Aug 03, 2023 | ☽ POST | $4.60 | $4.82 | $4.71 | 544,300 | -7.64% | open_in_new |
| May 17, 2023 | ☽ POST | $3.03 | $3.16 | $3.15 | 351,300 | +0% | open_in_new |
| Mar 09, 2023 | ☽ POST | $3.30 | $3.39 | $3.18 | 304,000 | -5.35% | open_in_new |
| Nov 10, 2022 | ☀ PRE | $2.43 | $2.62 | $2.60 | 853,600 | +7.88% | open_in_new |
| Aug 11, 2022 | ☽ POST | $10.35 | $10.50 | $9.75 | 213,307 | +11.69% | open_in_new |
| May 16, 2022 | ☀ PRE | $12.04 | $12.51 | $12.02 | 150,207 | +2.69% | open_in_new |
| Mar 28, 2022 | ☽ POST | $17.85 | $19.05 | $17.40 | 228,807 | +1.72% | open_in_new |
Earnings Count
18
Total earnings in dataset
Avg Abs. Movement
±5.49%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260519 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| 10-Q | 20260507 | open_in_new SEC.gov |
| 8-K | 20260507 | open_in_new SEC.gov |
| DEFA14A | 20260427 | open_in_new SEC.gov |
| DEF 14A | 20260427 | open_in_new SEC.gov |
| DEF 14A | 20260427 | open_in_new SEC.gov |
| DEFA14A | 20260427 | open_in_new SEC.gov |
| 8-K | 20260422 | open_in_new SEC.gov |
| 4 | 20260326 | open_in_new SEC.gov |
Frequently asked about DFTX earnings
When does Definium Therapeutics, Inc. report earnings next? expand_more
Definium Therapeutics, Inc. (DFTX)'s next earnings date is approximate for 2026-07-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does DFTX stock move after earnings? expand_more
Over 18 reports, DFTX has moved an average of ±5.49% the session after earnings, closing higher 55.6% of the time.
What was DFTX's biggest post-earnings move? expand_more
DFTX's largest post-earnings gain on record was +14.44% on Nov 02, 2023, and its largest decline was -7.64% on Aug 03, 2023.
Where can I find Definium Therapeutics, Inc.'s SEC filings? expand_more
All of Definium Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right